Category: Zacks Small Cap Research

12345220 / 514 POSTS
By Brian Marckx, CFANASDAQ:DRRX | NASDAQ:PCRXREAD THE FULL DRRX RESEARCH REPORTPOSIMIR CRL Response Made. Favorable Decision Would Likely Mean Significant Upside to Our ModelThis morning, Durect (NASDAQ:DRRX) announced that they submitted a full resp ...
By Brian Marckx, CFANASDAQ:APM | OTC:RHHBYREAD THE FULL APM RESEARCH REPORTAptorum Group Limited (NASDAQ:APM) went public through an initial public offering which closed in December 2018 and raised $12.0M (gross) from the sale of 761k common shares. ...
By John Vandermosten, CFANYSE:ZOM85 million American families own a pet, mostly split between 60 million dog owners and 47 million cat owners1. These animal companions need health care just like people do. The high level of ownership stimulates the $ ...
By Ian Gilson, PhD, CFANASDAQ:MBIIREAD THE FULL MBII RESEARCH REPORTOn June 25, 2019, Marrone Bio Innovations (NASDAQ:MBII) received notice that the major claims covering composition and method of manufacture of Grandevo WDG have been allowed.This me ...
By David Bautz, PhDNASDAQ:ORMPREAD THE FULL ORMP RESEARCH REPORTBusiness UpdateOramed Pharmaceuticals Inc. (NASDAQ:ORMP) is a biotechnology company with a proprietary oral protein delivery platform technology. The lead development candidate is ORMD-0 ...
By Brian Marckx, CFANASDAQ:MYOSREAD THE FULL MYOS RESEARCH REPORTYesterday, MYOS Rens Technology (NASDAQ:MYOS) announced topline results from a study conducted at the University of California, Berkeley which further supports the role of (their propri ...
By David Bautz, PhDNASDAQ:SPHSREAD THE FULL SPHS RESEARCH REPORTBusiness UpdateSophiris Bio Inc. (NASDAQ:SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyperpla ...
By Brian Marckx, CFAOTC:SMLRREAD THE FULL SMLR RESEARCH REPORTOn June 17th, Semler (OTC:SMLR) announced that while CEO Doug Murphy-Chutorian suffered a mild stroke following elective surgery, he continues to lead the company and the incident did not ...
By David Bautz, PhDTSX:MDNA.TO | OTC:MDNAFREAD THE FULL MDNA.TO RESEARCH REPORTBusiness UpdateOn June 18, 2019, Medicenna Therapeutics Corp. (TSX:MDNA) (OTC:MDNAF) announced the presentation of preliminary topline results from the company’s ongoing P ...
By John Vandermosten, CFANYSE:CVMIn late May 2019, Zacks was treated to an onsite tour of CEL-SCI’s (NYSE:CVM) 73,000 square foot manufacturing facility in Elkridge, Maryland. As we drove to the industrial park southwest of Baltimore, we came upon CE ...
12345220 / 514 POSTS